(taken from the application) The objective of this proposal is to establish a Clinical Trials Unit (CTU) at the Charles R. Drew University of Medicine and Science (Drew) in cooperation with the National Institutes of Health (NIH) that will facilitate the development and increase the number of core faculty trained in clinical investigation, behavioral science, and epidemiology. Drew is unique in that the culturally diverse community it cares for includes Hispanics (~65%), Blacks (~25%), and Asian/Pacific Islander/White (~10%), who suffer from a disproportionate mortality rate due to cardiovascular (and related) diseases, diabetes, cancer, accidents and intentional injuries, digestive diseases, infant mortality, HIV/AIDS, and substance use/abuse. The Drew CTU will focus on recruitment of women and underserved populations in many of these areas which remain an unmet challenge. The CTU will also serve as an interdisciplinary model for enhancing the participation of women and underserved populations in clinical trials. A unique Biobehavioral Core within the CTU will examine and evaluate how cultural, psychological, and socioeconomic differences impact on traditional methods used to implement clinical trials designed to improve access to and delivery of health care. The CTU implementation will be divided into two phases. Phase I (12 months) will focus on developing research infrastructure to include the recruitment of the Center Director, his/her administrator and research nurse coordinator. In conjunction with a national advisory committee, chaired by a NIH designate, the CTU Director will identify and develop a clinical pilot research project. Phase II (60 months) will begin the implementation of clinical trials, faculty development and the pilot research project.
The specific aims of phase II are to: a) develop and/or recruit innovative epidemiological, psycho-social, and biomedical clinical trials, emphasizing those that address health care issues that disproportionately affect women and underserved populations; b) create reproducible culturally and socioeconomically sensitive strategies for increasing recruitment and retention in clinical trials; c) create reproducible culturally and socioeconomically sensitive assessment tools for validating the responses/outcomes in clinical trials; d) increase mentoring relationships between experienced clinical investigators and junior faculty at Drew; and e) increase the number of NIH, Public Health Service (PHS), privately-funded, and industry-sponsored clinical trials at Drew.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01DK054047-06S2
Application #
6803868
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Agodoa, Lawrence Y
Project Start
1997-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
6
Fiscal Year
2003
Total Cost
$49,536
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Hsia, Stanley H (2011) Insulin glargine compared to NPH among insulin-naïve, U.S. inner city, ethnic minority type 2 diabetic patients. Diabetes Res Clin Pract 91:293-9
Calderon, Jose L; Baker, Richard S; Fabrega, Horacio et al. (2006) An ethno-medical perspective on research participation: a qualitative pilot study. MedGenMed 8:23
Hsia, Stanley H; Pan, Deyu; Berookim, Peyton et al. (2006) A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. Am J Cardiol 98:1047-52
Herbst, Karen L; Calof, Olga M; Hsia, Stanley H et al. (2006) Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss. Fertil Steril 85:1794-802
Singh, Atam B; Lee, Martin L; Sinha-Hikim, Indrani et al. (2006) Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab 91:136-44
Bhasin, Shalender; Woodhouse, Linda; Casaburi, Richard et al. (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90:678-88
Choi, H H; Gray, P B; Storer, T W et al. (2005) Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. J Clin Endocrinol Metab 90:1531-41
Woodhouse, Linda J; Gupta, Nidhi; Bhasin, Meenakshi et al. (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718-26
Davidson, Mayer B; Bazargan, Mohsen; Bakris, George et al. (2004) ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol 24:284-8
Hsia, Stanley H; Bazargan, Mohsen; Davidson, Mayer B (2004) Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism 53:1166-73

Showing the most recent 10 out of 24 publications